Head and Neck Neoplasms
286
32
44
137
Key Insights
Highlights
Success Rate
77% trial completion
Published Results
49 trials with published results (17%)
Research Maturity
137 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
41 terminated out of 286 trials
77.0%
-9.6% vs benchmark
10%
29 trials in Phase 3/4
36%
49 of 137 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 137 completed trials
Clinical Trials (286)
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
Biospecimen Procurement for Head and Neck Disorders
Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Intratumoral N17350 in Advanced Solid Tumors
Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
First in Human Study of AZD9592 in Solid Tumors
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor
Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Collection of Head Images During Radiotherapy
Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas